{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:17:58Z","timestamp":1782440278176,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10072-017-3148-6","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T03:16:07Z","timestamp":1508382967000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["THC\/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-9939","authenticated-orcid":false,"given":"Giorgia Teresa","family":"Maniscalco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Aponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Guarcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Moreggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Chiariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"issue":"1","key":"3148_CR1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0022-5347(01)67258-6","volume":"154","author":"EL Koldewijn","year":"1995","unstructured":"Koldewijn EL, Hommes OR, Lemmens WA, Debruyne FM, van Kerrebroeck PE (1995) Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol 154(1):169\u2013173","journal-title":"J Urol"},{"issue":"7","key":"3148_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/1352458506075651","volume":"13","author":"M S\u00e8ze de","year":"2007","unstructured":"de S\u00e8ze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B, GENULF (2007) The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 13(7):915\u2013928. \nhttps:\/\/doi.org\/10.1177\/1352458506075651","journal-title":"Mult Scler"},{"issue":"3","key":"3148_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0003-9993(98)90003-X","volume":"79","author":"P Gallien","year":"1998","unstructured":"Gallien P, Robineau S, Nicolas B, Le Bot MP, Brissot R, Verin M (1998) Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases. Arch Phys Med Rehabil 79(3):255\u2013257","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"3148_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1520-6777(1998)17:2<89::AID-NAU2>3.0.CO;2-8","volume":"17","author":"A Giannantoni","year":"1998","unstructured":"Giannantoni A, Scivoletto G, Di Stasi SM, Grasso MG, Vespasiani G, Castellano V (1998) Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients. Neurourol Urodyn 17(2):89\u201398","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"3148_CR5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0094-0143(05)70326-8","volume":"23","author":"JL Hinson","year":"1996","unstructured":"Hinson JL, Boone TB (1996) Urodynamics and multiple sclerosis. Urol Clin North Am 23(3):475\u2013481","journal-title":"Urol Clin North Am"},{"issue":"5, Suppl 1","key":"3148_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0090-4295(02)01784-3","volume":"60","author":"AJ Wein","year":"2002","unstructured":"Wein AJ, Rovner ES (2002) Definition and epidemiology of overactive bladder. Urology 60(5, Suppl 1):7\u201312","journal-title":"Urology"},{"issue":"4","key":"3148_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MOU.0000000000000290","volume":"26","author":"CJ Harris","year":"2016","unstructured":"Harris CJ, Lemack GE (2016) Neurourologic dysfunction: evaluation, surveillance and therapy. Curr Opin Urol 26(4):290\u2013294. \nhttps:\/\/doi.org\/10.1097\/MOU.0000000000000290","journal-title":"Curr Opin Urol"},{"issue":"7","key":"3148_CR8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/ene.13010","volume":"23","author":"C Zecca","year":"2016","unstructured":"Zecca C, Riccitelli GC, Disanto G, Singh A, Digesu GA, Panicari L, Puccini F, Mattioli M, Tubaro A, Gobbi C (2016) Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients\u2019 quality of life. Eur J Neurol 23(7):1228\u20131234. \nhttps:\/\/doi.org\/10.1111\/ene.13010","journal-title":"Eur J Neurol"},{"issue":"6","key":"3148_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/ene.13010","volume":"32","author":"A Ghezzi","year":"2011","unstructured":"Ghezzi A, Carone R, Del Popolo G, Amato MP, Bertolotto A, Comola M, Del Carro U, Di Benedetto P, Giannantoni A, Lopes de Carvalho ML, Montanari E, Patti F, Protti A, Rasia S, Salonia A, Scandellari C, Sperli F, Spinelli M, Solaro C, Uccelli A, Zaffaroni M, Zipoli V, Multiple Sclerosis Study Group, Italian Society of Neurology (2011) Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian multiple sclerosis study group. Neurol Sci 32(6):1223\u20131231. \nhttps:\/\/doi.org\/10.1111\/ene.13010","journal-title":"Neurol Sci"},{"issue":"40","key":"3148_CR10","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta7400","volume":"7","author":"S Beard","year":"2003","unstructured":"Beard S, Hunn A, Wight J (2003) Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess 7(40):iii ix-x,1\u2013111","journal-title":"Health Technol Assess"},{"issue":"9","key":"3148_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","volume":"18","author":"A Novotna","year":"2011","unstructured":"Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, Gasperini C, Pozzilli C, Cefaro L, Comi G, Rossi P, Ambler Z, Stelmasiak Z, Erdmann A, Montalban X, Klimek A, Davies P, Sativex Spasticity Study Group (2011) A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(\u00ae) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 18(9):1122\u20131231. \nhttps:\/\/doi.org\/10.1111\/j.1468-1331.2010.03328.x","journal-title":"Eur J Neurol"},{"issue":"2","key":"3148_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","volume":"66","author":"E Russo","year":"2006","unstructured":"Russo E, Guy GW (2006) A tale of two cannabinoids: the therapeutic rationale for combining tetrahydro-cannabinol and cannabidiol. Med Hypotheses 66(2):234\u2013246. \nhttps:\/\/doi.org\/10.1016\/j.mehy.2005.08.026","journal-title":"Med Hypotheses"},{"issue":"8949","key":"3148_CR13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(95)90485-9","volume":"345","author":"CN Martyn","year":"1995","unstructured":"Martyn CN, Illis LS, Thom J (1995) Nabilone in the treatment of multiple sclerosis. Lancet 345(8949):579","journal-title":"Lancet"},{"issue":"11","key":"3148_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/1352458510378020","volume":"16","author":"RB Kavia","year":"2010","unstructured":"Kavia RB, De Ridder D, Constantinescu CS, Stott CG, Fowler CJ (2010) Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler 16(11):1349\u20131359. \nhttps:\/\/doi.org\/10.1177\/1352458510378020","journal-title":"Mult Scler"},{"issue":"4","key":"3148_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1191\/1352458504ms1063oa","volume":"10","author":"CM Brady","year":"2004","unstructured":"Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ (2004) An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler 10(4):425\u2013433. \nhttps:\/\/doi.org\/10.1191\/1352458504ms1063oa","journal-title":"Mult Scler"},{"issue":"5","key":"3148_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1179\/016164109X12590518685660","volume":"32","author":"C Collin","year":"2010","unstructured":"Collin C, Ehler E, Waberzinek G, Alsindi Z, Davies P, Powell K, Notcutt W, O'Leary C, Ratcliffe S, Nov\u00e1kov\u00e1 I, Zapletalova O, Pikov\u00e1 J, Ambler Z (2010) A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res 32(5):451\u2013459. \nhttps:\/\/doi.org\/10.1179\/016164109X12590518685660","journal-title":"Neurol Res"},{"issue":"1","key":"3148_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/nau.22442","volume":"33","author":"P Hedlund","year":"2014","unstructured":"Hedlund P (2014) Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction. Neurourol Urodyn 33(1):46\u201353. \nhttps:\/\/doi.org\/10.1002\/nau.22442","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"3148_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/0970-1591.60440","volume":"26","author":"P Tyagi","year":"2010","unstructured":"Tyagi P, Tyagi V, Yoshimura N, Chancellor M (2010) Functional role of cannabinoid receptors in urinary bladder. Indian J Urol 26(1):26\u201335. \nhttps:\/\/doi.org\/10.4103\/0970-1591.60440","journal-title":"Indian J Urol"},{"issue":"8","key":"3148_CR19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1139\/cjpp-2015-0091","volume":"93","author":"K Juszczak","year":"2015","unstructured":"Juszczak K, Maciukiewicz P (2015) The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats. Can J Physiol Pharmacol 93(8):721\u2013726","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"3148_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. \nhttps:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"issue":"5","key":"3148_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.clinthera.2008.05.011","volume":"30","author":"JT Farrar","year":"2008","unstructured":"Farrar JT, Troxel AB, Stott C, Duncombe P, Jensen MP (2008) Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther 30(5):974\u2013985. \nhttps:\/\/doi.org\/10.1016\/j.clinthera.2008.05.011","journal-title":"Clin Ther"},{"issue":"2","key":"3148_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.juro.2007.03.133","volume":"178","author":"JG Blaivas","year":"2007","unstructured":"Blaivas JG, Panagopoulos G, Weiss JP, Somaroo C (2007) Validation of the overactive bladder symptom score. J Urol 178(2):543\u2013547. \nhttps:\/\/doi.org\/10.1016\/j.juro.2007.03.133","journal-title":"J Urol"},{"issue":"1","key":"3148_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000136645","volume":"31","author":"JF Kurtzke","year":"2008","unstructured":"Kurtzke JF (2008) Historical and clinical perspectives of the expanded disability status scale. Neuroepidemiology 31(1):1\u20139. \nhttps:\/\/doi.org\/10.1159\/000136645","journal-title":"Neuroepidemiology"},{"issue":"2","key":"3148_CR24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","volume":"67","author":"RW Bohannon","year":"1987","unstructured":"Bohannon RW, Smith MB (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67(2):206\u2013207","journal-title":"Phys Ther"},{"issue":"4","key":"3148_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/135245850000600411","volume":"6","author":"M Kaufman","year":"2000","unstructured":"Kaufman M, Moyer D, Norton J (2000) The significant change for the timed 25-foot walk in the multiple sclerosis functional composite. Mult Scler 6(4):286\u2013290. \nhttps:\/\/doi.org\/10.1177\/135245850000600411","journal-title":"Mult Scler"},{"issue":"3","key":"3148_CR26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","volume":"21","author":"W Sch\u00e4fer","year":"2002","unstructured":"Sch\u00e4fer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P, International Continence Society (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21(3):261\u2013274","journal-title":"Neurourol Urodyn"},{"key":"3148_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000357427","volume":"71","author":"P Flachenecker","year":"2014","unstructured":"Flachenecker P, Henze T, Zettl UK (2014) Nabiximols (THC\/CBD Oromucosal spray, Sativex \u00ae) in clinical practice\u2014results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. Eur Neurol 71:173\u2013181. \nhttps:\/\/doi.org\/10.1159\/000357427","journal-title":"Eur Neurol"},{"issue":"9","key":"3148_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/jnnp-2015-312591","volume":"87","author":"F Patti","year":"2016","unstructured":"Patti F, Messina S, Solaro C, Amato MP, Bergamaschi R, Bonavita S, Bruno Bossio R, Brescia Morra V, Costantino GF, Cavalla P, Centonze D, Comi G, Cottone S, Danni M, Francia A, Gajofatto A, Gasperini C, Ghezzi A, Iudice A, Lus G, Maniscalco GT, Marrosu MG, Matta M, Mirabella M, Montanari E, Pozzilli C, Rovaris M, Sessa E, Spitaleri D, Trojano M, Valentino P, Zappia M, on behalf of the SA.FE. study group (2016) Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. J Neurol Neurosurg Psychiatry 87(9):944\u2013951. \nhttps:\/\/doi.org\/10.1136\/jnnp-2015-312591","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3148_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000449413","volume":"76","author":"P Vermersch","year":"2016","unstructured":"Vermersch P, Trojano M (2016) Tetrahydrocannabinol:cannabidiol oromucosal spray for multiple sclerosis-related resistant spasticity in daily practice. Eur Neurol 76:216\u2013226. \nhttps:\/\/doi.org\/10.1159\/000449413","journal-title":"Eur Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-3148-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3148-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3148-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T23:33:17Z","timestamp":1516145597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-3148-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3148"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-3148-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}